Policy Notices

• Reminder: Required use of FORMS-F application forms for application submission
  (NOT-OD-21-104)
  National Institutes of Health
  

General Notices

• Updated NCI Guidance Concerning the Mentored Clinical Scientist Research Career Development Award: Percent Effort of Surgeon-Scientists for K08 awards from NCI
  (NOT-CA-21-054)
  National Cancer Institute
  

• Continuation of Temporary Extension of Eligibility for the NIH K99/R00 Pathway to Independence Award During the COVID-19 Pandemic
  (NOT-OD-21-106)
  National Institutes of Health
  

• Notice of Pre-Application Webinar for Funding Opportunities on Transformative Research to Address Health Disparities and Advance Health Equity
  (NOT-RM-21-025)
  Office of Strategic Coordination (Common Fund)
  

• Request for Information (RFI): Research Challenges and Needs in Developing Chronomedicine for Health and Diseases
  (NOT-CA-21-042)
  National Cancer Institute
  National Heart, Lung, and Blood Institute
  National Institute on Drug Abuse
  National Institute of Neurological Disorders and Stroke
  

Notice of Changes to Funding Opportunities

• Notice of NIAAA Participation in NOT-OD-21-087 "Notice of Special Interest (NOSI): Developing and Testing Multilevel Physical Activity Interventions to Improve Health and Well-Being"
  (NOT-AA-21-013)
  National Institute on Alcohol Abuse and Alcoholism
  

• Notice of NIAAA Participation in NOT-OD-21-085 "Notice of Intent to Reissue PAR-18-307 " Developing Interventions for Health-Enhancing Physical Activity (R21/R33 - Clinical Trial Optional)" as a Notice of Special Interest (NOSI)"
  (NOT-AA-21-014)
  National Institute on Alcohol Abuse and Alcoholism
  

• Notice of NIAAA Participation in NOT-OD-21-086 "Notice of Intent to Reissue PAR-18-324 "Testing Interventions for Health-Enhancing Physical Activity (R01 - Clinical Trial Optional)" as a Notice of Special Interest (NOSI)"
  (NOT-AA-21-015)
  National Institute on Alcohol Abuse and Alcoholism
  

• Notice of Change: Extension and Additional Key Dates for NIAAA RFA-AA-21-002 "SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R01 Clinical Trial Not Allowed)"
  (NOT-AA-21-025)
  National Institute on Alcohol Abuse and Alcoholism
  

• Notice of Change: Extension and Additional Key Dates for NIAAA RFA-AA-21-003 "SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R03 Clinical Trial Not Allowed)"
  (NOT-AA-21-026)
  National Institute on Alcohol Abuse and Alcoholism
  

• Notice of Change: Extension and Additional Key Dates for NIAAA RFA-AA-21-004 "SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R21 Clinical Trial Not Allowed)"
  (NOT-AA-21-027)
  National Institute on Alcohol Abuse and Alcoholism
  

• Notice of Change: Receipt date added for RFA-EB-20-002, "BRAIN Initiative: Theories, Models and Methods for Analysis of Complex Data from the Brain (R01 Clinical Trial Not Allowed)
  (NOT-EB-21-006)
  National Institute of Biomedical Imaging and Bioengineering
  National Center for Complementary and Integrative Health
  National Eye Institute
  National Institute on Aging
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Mental Health
  National Institute of Neurological Disorders and Stroke
  Office of Behavioral and Social Sciences Research
  

• Notice of Clarification of Resubmission Due dates for RFA-RM-21-012, Pilot Projects Investigating Understudied G Protein-Coupled Receptors, Ion Channels, and Protein Kinases (R03 Clinical Trial Not Allowed)
  (NOT-RM-21-024)
  Office of Strategic Coordination (Common Fund)
  

• Notice of Addition of Requested Institutional Information for RFA-RM-21-022 - Transformative Research to Address Health Disparities and Advance Health Equity at Minority Serving Institutions
  (NOT-RM-21-026)
  Office of Strategic Coordination (Common Fund)
  

Notices of Intent to Publish

• Notice of Intent to Publish a Funding Opportunity Announcement for Collaborative Initiative on Fetal Alcohol Spectrum Disorders (CIFASD), Research Project (U01 Clinical Trial optional)
  (NOT-AA-21-020)
  National Institute on Alcohol Abuse and Alcoholism
  

• Notice of Intent to Publish a Funding Opportunity Announcement for Collaborative Initiative on Fetal Alcohol Spectrum Disorders (CIFASD), Administrative Core (U24) (Clinical Trial Not Allowed)
  (NOT-AA-21-021)
  National Institute on Alcohol Abuse and Alcoholism
  

• Notice of Intent to Publish a Funding Opportunity Announcement for Collaborative Initiative on Fetal Alcohol Spectrum Disorders (CIFASD), Diagnostic-Telemedicine Core (U24 Clinical Trial Not Allowed)
  (NOT-AA-21-022)
  National Institute on Alcohol Abuse and Alcoholism
  

• Notice of Intent to Publish a Funding Opportunity Announcement for Collaborative Initiative on Fetal Alcohol Spectrum Disorders (CIFASD), Data Coordination Core (U24 Clinical Trial Not Allowed)
  (NOT-AA-21-023)
  National Institute on Alcohol Abuse and Alcoholism
  

• Notice of Intent to Publish a Funding Opportunity Announcement for Collaborative Initiative on Fetal Alcohol Spectrum Disorders (CIFASD), Developmental Project (UH2 Clinical Trial Optional)
  (NOT-AA-21-024)
  National Institute on Alcohol Abuse and Alcoholism
  

• Notice of Intent to Publish a Funding Opportunity Announcement for Non-Human Primate Developmental Genotype-Tissue Expression (NHP dGTEx) Project (U24 Clinical Trials Not Allowed)
  (NOT-HG-21-027)
  National Human Genome Research Institute
  National Institute of Mental Health
  

Notices of Special Interest

• Notice of Special Interest (NOSI): Telehealth in Cancer Care
  (NOT-CA-21-043)
  National Cancer Institute
  

• Notice of Special Interest (NOSI): Administrative Supplement for Modifiable Factors Potentially affecting the Cost of Cancer Treatment
  (NOT-CA-21-055)
  National Cancer Institute
  

• Notice of Special Interest (NOSI) Announcing the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus
  (NOT-DA-21-041)
  National Institute on Drug Abuse
  

• Notice of Special Interest (NOSI): Administrative Supplements for Workforce Development at the Interface of Information Sciences, Artificial Intelligence and Machine Learning (AI/ML), and Biomedical Sciences
  (NOT-OD-21-079)
  National Institutes of Health
  National Cancer Institute
  National Eye Institute
  National Human Genome Research Institute
  National Heart, Lung, and Blood Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Allergy and Infectious Diseases
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute on Drug Abuse
  National Institute of Environmental Health Sciences
  National Institute of General Medical Sciences
  National Institute of Mental Health
  National Institute of Neurological Disorders and Stroke
  National Institute of Nursing Research
  Office of Research on Women's Health
  

• Notice of Special Interest (NOSI): Administrative Supplements for Rapid Acceleration of Diagnostics-Underserved Populations (RADx-UP) Phase I Projects to Address Vaccine Hesitancy and Uptake
  (NOT-OD-21-101)
  National Institutes of Health
  National Center for Advancing Translational Sciences
  National Center for Complementary and Integrative Health
  National Cancer Institute
  National Heart, Lung, and Blood Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Allergy and Infectious Diseases
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Drug Abuse
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Environmental Health Sciences
  National Institute of General Medical Sciences
  National Institute of Mental Health
  National Institute on Minority Health and Health Disparities
  National Institute of Nursing Research
  National Library of Medicine
  

• Notice of Special Interest (NOSI): Emergency Competitive Revisions for Community-engaged COVID-19 Testing Interventions among Underserved and Vulnerable Populations RADx-UP Phase II (Emergency Supplement - Clinical Trial Optional)
  (NOT-OD-21-103)
  National Institutes of Health
  National Center for Advancing Translational Sciences
  National Center for Complementary and Integrative Health
  National Cancer Institute
  National Eye Institute
  National Human Genome Research Institute
  National Heart, Lung, and Blood Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Allergy and Infectious Diseases
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute of Biomedical Imaging and Bioengineering
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Environmental Health Sciences
  National Institute of General Medical Sciences
  National Institute of Mental Health
  National Institute on Minority Health and Health Disparities
  National Institute of Neurological Disorders and Stroke
  National Institute of Nursing Research
  National Library of Medicine
  Office of Behavioral and Social Sciences Research
  Office of Disease Prevention
  Office of Research on Women's Health
  

• Notice of Special Interest (NOSI): Topic Areas for PAR-21-203, Limited Competition: Clinical and Translational Science Award (CTSA) Consortium-Wide Centers: Resources for Rapid Demonstration and Dissemination (U24 Clinical Trials Not Allowed)
  (NOT-TR-21-025)
  National Center for Advancing Translational Sciences
  

Funding Opportunities

• Limited Competition: Development and Renovation of Research Space for HIV/AIDS Research at Institutions Serving Underrepresented Populations or Located in Institutional Development Award (IDeA)-eligible States (C06 Clinical Trial Not Allowed)
  (PAR-21-159)
  Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
  Application Receipt Date(s): See announcement.
  
  

• Enhancing NIDCD's Extramural Workforce Diversity through Research Experiences (R25 Clinical Trial Not Allowed)
  (PAR-21-186)
  National Institute on Deafness and Other Communication Disorders
  Application Receipt Date(s): May 28, 2021; September 24, 2021; January 27, 2022; May 27, 2022; September 21, 2022; January 27, 2023; May 26, 2023; September 26, 2023; January 29, 2024.
  
  

• 3D Technologies to Accelerate HTAN Atlas Building Efforts (UH2 Clinical Trial Not Allowed)
  (RFA-CA-21-037)
  National Cancer Institute
  Application Receipt Date(s): Multiple dates, see announcement.
  
  

• Population Dynamics Centers Research Infrastructure Program FY 2022 (P2C Clinical Trial Not Allowed)
  (RFA-HD-22-013)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  Application Receipt Date(s): July 29, 2021
  
  

• Coordinating Center for the NICHD Population Dynamics Centers Research Infrastructure Program FY 2022 (R24 Clinical Trial Not Allowed)
  (RFA-HD-22-014)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  Application Receipt Date(s): Multiple dates, see announcement.
  
  

• Biomarker Research to Support Fertility Regulation Development by Small Business (R43 Clinical Trial Optional)
  (RFA-HD-22-018)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  Application Receipt Date(s): July 29, 2021
  
  

• Centers for Multiple Chronic Diseases Associated with Health Disparities: Prevention, Treatment, and Management (P50 Clinical Trial Required)
  (RFA-MD-21-007)
  National Institute on Minority Health and Health Disparities
  Application Receipt Date(s): See announcement.
  
  

• NIMHD Multiple Chronic Disease Disparities Research Coordinating Center (RCC) (U24 Clinical Trial Not Allowed)
  (RFA-MD-21-008)
  National Institute on Minority Health and Health Disparities
  Application Receipt Date(s): See announcement.
  
  

• Emergency Awards: Community-engaged COVID-19 Testing Interventions among Underserved and Vulnerable Populations RADx-UP Phase II (U01 Clinical Trial Optional)
  (RFA-OD-21-008)
  National Institutes of Health
  National Center for Advancing Translational Sciences
  National Center for Complementary and Integrative Health
  National Cancer Institute
  National Eye Institute
  National Human Genome Research Institute
  National Heart, Lung, and Blood Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Allergy and Infectious Diseases
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute of Biomedical Imaging and Bioengineering
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Environmental Health Sciences
  National Institute of General Medical Sciences
  National Institute of Mental Health
  National Institute on Minority Health and Health Disparities
  National Institute of Neurological Disorders and Stroke
  National Institute of Nursing Research
  National Library of Medicine
  Office of Behavioral and Social Sciences Research
  Office of Disease Prevention
  Office of Research on Women's Health
  Application Receipt Date(s): July 07, 2021
  
  

• Emergency Award: RADx-UP - Social, Ethical, and Behavioral Implications (SEBI) Research on Disparities in COVID-19 Testing among Underserved and Vulnerable Populations (U01 Clinical Trials Optional)
  (RFA-OD-21-009)
  National Institutes of Health
  National Center for Advancing Translational Sciences
  National Center for Complementary and Integrative Health
  National Cancer Institute
  National Eye Institute
  National Human Genome Research Institute
  National Heart, Lung, and Blood Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Allergy and Infectious Diseases
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute of Biomedical Imaging and Bioengineering
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Environmental Health Sciences
  National Institute of General Medical Sciences
  National Institute of Mental Health
  National Institute on Minority Health and Health Disparities
  National Institute of Neurological Disorders and Stroke
  National Institute of Nursing Research
  National Library of Medicine
  Office of Behavioral and Social Sciences Research
  Office of Disease Prevention
  Office of Research on Women's Health
  Application Receipt Date(s): July 07, 2021